Literature DB >> 29312757

Prevention of chronic rejection after lung transplantation.

Anke Van Herck1,2, Stijn E Verleden2, Bart M Vanaudenaerde2, Geert M Verleden1,2, Robin Vos1,2.   

Abstract

Long-term survival after lung transplantation (LTx) is limited by chronic rejection (CR). Therapeutic strategies for CR have been largely unsuccessful, making prevention of CR an important and challenging therapeutic approach. In the current review, we will discuss current clinical evidence regarding prevention of CR after LTx.

Entities:  

Keywords:  Chronic lung allograft dysfunction; lung transplantation (LTx); prevention; treatment

Year:  2017        PMID： 29312757      PMCID： PMC5756981          DOI： 10.21037/jtd.2017.11.85

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  184 in total

1.  Laparoscopic antireflux surgery in the lung transplant population.

Authors:  C L Lau; S M Palmer; D N Howell; R McMahon; D Hadjiliadis; J Gaca; T N Pappas; R D Davis; S Eubanks
Journal:  Surg Endosc       Date:  2002-07-29       Impact factor: 4.584

2.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

Review 3.  Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy.

Authors:  Anna L Taylor; Christopher J E Watson; J Andrew Bradley
Journal:  Crit Rev Oncol Hematol       Date:  2005-10       Impact factor: 6.312

4.  Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.

Authors:  Elfriede Ruttmann; Christian Geltner; Brigitte Bucher; Hanno Ulmer; Daniel Höfer; Herbert B Hangler; Severin Semsroth; Raimund Margreiter; Günther Laufer; Ludwig C Müller
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

5.  A randomized trial of inhaled cyclosporine in lung-transplant recipients.

Authors:  Aldo T Iacono; Bruce A Johnson; Wayne F Grgurich; J Georges Youssef; Timothy E Corcoran; Deidre A Seiler; James H Dauber; Gerald C Smaldone; Adriana Zeevi; Samuel A Yousem; John J Fung; Gilbert J Burckart; Kenneth R McCurry; Bartley P Griffith
Journal:  N Engl J Med       Date:  2006-01-12       Impact factor: 91.245

6.  Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.

Authors:  Geert M Verleden; Stijn E Verleden; Robin Vos; Stéphanie I De Vleeschauwer; Lieven J Dupont; Dirk E Van Raemdonck; Bart M Vanaudenaerde
Journal:  Transpl Int       Date:  2011-03-14       Impact factor: 3.782

7.  Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.

Authors:  Raksha Jain; Ramsey R Hachem; Matthew R Morrell; Elbert P Trulock; Murali M Chakinala; Roger D Yusen; Howard J Huang; Thalachallour Mohanakumar; G Alexander Patterson; Michael J Walter
Journal:  J Heart Lung Transplant       Date:  2010-02-04       Impact factor: 10.247

8.  Long-term outcomes following alemtuzumab induction in lung transplantation.

Authors:  Brody Wehman; Bartley P Griffith; Akshu Balwan; Zachary N Kon; Dante A Suffredini; Charles Evans; Jose P Garcia; Aldo Iacono
Journal:  Heart Surg Forum       Date:  2013-10       Impact factor: 0.676

9.  Gastroesophageal reflux disease in lung transplant recipients.

Authors:  Denis Hadjiliadis; R Duane Davis; Mark P Steele; Robert H Messier; Christine L Lau; Steve S Eubanks; Scott M Palmer
Journal:  Clin Transplant       Date:  2003-08       Impact factor: 2.863

10.  Pseudomonas aeruginosa Induced Airway Epithelial Injury Drives Fibroblast Activation: A Mechanism in Chronic Lung Allograft Dysfunction.

Authors:  L A Borthwick; M I Suwara; S C Carnell; N J Green; R Mahida; D Dixon; C S Gillespie; T N Cartwright; J Horabin; A Walker; E Olin; M Rangar; A Gardner; J Mann; P A Corris; D A Mann; A J Fisher
Journal:  Am J Transplant       Date:  2016-02-26       Impact factor: 8.086
View more
  1 in total

1.  Xenogeneic cross-circulation for extracorporeal recovery of injured human lungs.

Authors:  Ahmed E Hozain; John D O'Neill; Matthew Bacchetta; Gordana Vunjak-Novakovic; Meghan R Pinezich; Yuliya Tipograf; Rachel Donocoff; Katherine M Cunningham; Andrew Tumen; Kenmond Fung; Rei Ukita; Michael T Simpson; Jonathan A Reimer; Edward C Ruiz; Dawn Queen; John W Stokes; Nancy L Cardwell; Jennifer Talackine; Jinho Kim; Hans-Willem Snoeck; Ya-Wen Chen; Alexander Romanov; Charles C Marboe; Adam D Griesemer; Brandon A Guenthart
Journal:  Nat Med       Date:  2020-07-13       Impact factor: 87.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.